Screener
Maze Therapeutics MAZE Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Maze Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Maze Therapeutics’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344903
FAQ
- What is Maze Therapeutics's retained earnings?
- Maze Therapeutics (MAZE) reported retained earnings of -$558.48M in Q2 2026.
- How has Maze Therapeutics's retained earnings changed year-over-year?
- Maze Therapeutics's retained earnings decreased by 31.4% year-over-year, from -$424.89M to -$558.48M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Maze Therapeutics's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude